{"id":"W2589103622","doi":"10.1016/j.cllc.2017.02.001","title":"Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Clinical Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Atezolizumab; Pemetrexed; Nivolumab; Internal medicine; Oncology; Erlotinib; Lung cancer; Hazard ratio; Docetaxel; Adverse effect; Gefitinib; Chemotherapy; Erlotinib Hydrochloride; Epidermal growth factor receptor; Cancer; Immunotherapy; Confidence interval; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001761478,0.001113158,0.009390503,0.0001417918,0.000264143,0.00007533989,0.0007982936,0.0007309461,0.0001973294],"category_scores_gemma":[0.0006757211,0.0006966112,0.003422855,0.0003330067,0.000266935,0.000126587,0.0001500179,0.001038734,0.00001395393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001239896,"about_ca_system_score_gemma":0.0030112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001219203,"about_ca_topic_score_gemma":0.00005892661,"domain_scores_codex":[0.9925739,0.0002744697,0.004481616,0.001298878,0.0005885652,0.000782642],"domain_scores_gemma":[0.9912592,0.0007154936,0.004835337,0.002171535,0.0006386427,0.0003797783],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0005962002,0.0002940893,0.0004280815,0.760839,0.002422559,0.000008093878,0.00001528071,1.14827e-7,3.197532e-7,3.962924e-7,0.004180857,0.231215],"study_design_scores_gemma":[0.004306166,0.0005397195,0.00007367997,0.620988,0.02306928,0.000004523376,0.000002956652,0.00001135341,0.000001553245,2.989404e-7,0.3504078,0.0005946839],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005713684,0.9681483,0.00002447058,0.0002414596,0.002819763,0.02793255,0.0004448774,0.00007926948,0.0002522095],"genre_scores_gemma":[0.00001476992,0.9779879,0.0002374036,0.0008437759,0.0009459504,0.01563559,0.0003687108,0.0002693559,0.003696554],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3462269,"threshold_uncertainty_score":0.9995485,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0542220111495793,"score_gpt":0.4328983314420488,"score_spread":0.3786763202924694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}